RECRUITING

The VENTOR Clinical Study

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

To evaluate the initial safety and effectiveness of the Ventor Airway System in providing short-term ventilation support in non-breathing subjects during cardiopulmonary resuscitation (CPR) and respiratory arrests.

Official Title

The VENTOR Clinical Study - VENTilation and Airway Optimization for Cardiac Arrest Resuscitation

Quick Facts

Study Start:2025-04-04

Study Completion:2026-06

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:RECRUITING

Study ID

NCT06759389

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 75 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
1. Adults aged 18-75 years, inclusive 2. IHCA (non-traumatic) 3. At least 4 feet in height	1. Intubated with an endotracheal tube (ET) 2. Valid do-not-attempt-resuscitation (DNAR) or study opt-out bracelet (including previous enrollment bracelet) 3. LAR or Family member objects to enrollment 4. Obvious signs of irreversible death (rigor mortis, dependent lividity, decapitation, transection, decomposition) 5. Responsive with an intact gag reflex 6. Blunt, penetrating, or burn-related injury, drowning, or electrocution 7. Known upper airway foreign body or mass 8. Lower airway obstruction 9. Dental gap of \< 2 cm 10. Ingested caustic substances 11. Medicine Admitting Note's medical history is incomplete or has only been completed by an emergency physician. 12. Known esophageal disease or facial/perforating neck trauma defined as study candidates with the following medical history: 1. Diseases: (Esophageal Varices, Esophageal Cancer, Esophageal Strictures) 2. Any patient on the following medications will be excluded: (Oxaliplatin, Leucovorin, Fluorouracil) 3. Any patient with the following examination findings will be excluded: (Caput medusae, History or evidence of vomiting blood) 13. Known vulnerable subject other Inclusion #3, such as known (e.g.: prisoner, pregnancy, terminal illness, dementia) 14. History of medical, surgical or other conditions that, in the opinion of the investigator, would limit study participation

Inclusion Criteria

Exclusion Criteria

1. Adults aged 18-75 years, inclusive
2. IHCA (non-traumatic)
3. At least 4 feet in height

1. Intubated with an endotracheal tube (ET)
2. Valid do-not-attempt-resuscitation (DNAR) or study opt-out bracelet (including previous enrollment bracelet)
3. LAR or Family member objects to enrollment
4. Obvious signs of irreversible death (rigor mortis, dependent lividity, decapitation, transection, decomposition)
5. Responsive with an intact gag reflex
6. Blunt, penetrating, or burn-related injury, drowning, or electrocution
7. Known upper airway foreign body or mass
8. Lower airway obstruction
9. Dental gap of \< 2 cm
10. Ingested caustic substances
11. Medicine Admitting Note's medical history is incomplete or has only been completed by an emergency physician.
12. Known esophageal disease or facial/perforating neck trauma defined as study candidates with the following medical history:
1. Diseases: (Esophageal Varices, Esophageal Cancer, Esophageal Strictures)
2. Any patient on the following medications will be excluded: (Oxaliplatin, Leucovorin, Fluorouracil)
3. Any patient with the following examination findings will be excluded: (Caput medusae, History or evidence of vomiting blood)
13. Known vulnerable subject other Inclusion #3, such as known (e.g.: prisoner, pregnancy, terminal illness, dementia)
14. History of medical, surgical or other conditions that, in the opinion of the investigator, would limit study participation

Contacts and Locations

Study Contact

Clay Nolan

CONTACT

(800) 592-6241

clayn@colabsmedical.com

Principal Investigator

Jignesh Patel, M.D., M.Sc.

PRINCIPAL_INVESTIGATOR

Stony Brook University Hospital

Study Locations (Sites)

Stony Brook University Hospital

Stony Brook, New York, 11794

United States

Collaborators and Investigators

Sponsor: CoLabs Medical

Jignesh Patel, M.D., M.Sc., PRINCIPAL_INVESTIGATOR, Stony Brook University Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2025-04-04

Study Completion Date2026-06

Study Record Updates

Study Start Date2025-04-04

Study Completion Date2026-06

Terms related to this study

Additional Relevant MeSH Terms

Cardiac Arrest (CA)